UW Today

Data suggest new class of drug may be potent against genital herpes

A new drug, called pritelivir, may offer a new treatment option for patients with genital herpes, a new industry-sponsored – study led by University of Washington researchers has found.

Initial positive results reported on vaccine to treat genital herpes

The vaccine is the first to significantly reduce the frequency of viral shedding — the surfacing of herpes virus on the genitals — and appears to activate T cell immune responses to the virus.